Brain MRI Lesion Load at 1.5T and 3T versus Clinical Status in Multiple Sclerosis

Journal of Neuroimaging

Volumn 21, Issue 2, 2011, Pages

  Stankiewicz, James M ^a   Glanz, Bonnie I ^a   Healy, Brian C ^a,b   Arora, Ashish ^a   Neema, Mohit ^a   Benedict, Ralph H B ^a,c   Guss, Zachary D ^a   Tauhid, Shahamat ^a   Buckle, Guy J ^a   Houtchens, Maria K ^a   Khoury, Samia J ^a   Weiner, Howard L ^a   Guttmann, Charles R G ^a,b   Bakshi, Rohit ^a  

^a Brigham ^*  (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

1.5T; 3T; Cognitive testing; MRI; Multiple sclerosis

Indexed keywords

ADULT; ARTICLE; BRAIN DAMAGE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE DURATION; FEMALE; HUMAN; IMAGING SYSTEM; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; BRAIN; CASE-CONTROL STUDIES; COGNITION DISORDERS; DISABILITY EVALUATION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 79953051184     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2009.00449.x     Document Type: Article

References (53)

1. Rao SM, Leo GJ, Bernardin L, et al. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991;41(5):685-691.
2. Benedict RH, Cookfair D, Gavett R, et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006;12(4):549-558.
3. Mitchell AJ, Benito-León J, González JM, et al. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol 2005;4(9):556-566.
4. Benedict RH, Wahlig E, Bakshi R, et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005;231(1-2):29-34.
5. Rao SM, Leo GJ, Ellington L, et al. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991;41(5):692-696.
6. Glanz BI, Holland CM, Gauthier SA, et al. Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Mult Scler 2007;13(8):1004-1010.
7. Winkelmann A, Engel C, Apel A, et al. Cognitive impairment in multiple sclerosis. J Neurol 2007;254(Suppl 2):S35-S42.
8. Barkhof F. MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult Scler 1999;5(4):283-286.
9. Zivadinov R, Leist TP. Clinical-magnetic resonance imaging correlations in multiple sclerosis. J Neuroimaging 2005;15(Suppl 4):10S-21S.
10. Lazeron RH, Boringa JB, Schouten M, et al. Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis. Mult Scler 2005;11(5):524-531.
11. Sperling RA, Guttmann CR, Hohol MJ, et al. Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. Arch Neurol 2001;58(1):115-121.
12. Wattjes MP, Harzheim M, Kuhl CK, et al. Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic MR imaging criteria for multiple sclerosis? AJNR Am J Neuroradiol 2006;27(8):1794-1798.
13. Bakshi R, Thompson AJ, Rocca MA, et al. MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 2008;7(7):615-625.
14. U.S. Department of Health and Human Services. Criteria for Significant Risk Investigations of Magnetic Resonance Diagnostic Devices, 2003. Available at:, Accessed November 14, 2008.
15. Sicotte NL, Voskuhl RR, Bouvier S, et al. Comparison of multiple sclerosis lesions at 1.5 and 3.0 Tesla. Invest Radiol 2003;38(7):423-427.
16. Keiper MD, Grossman RI, Hirsch JA, et al. MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5 T and 4 T. AJNR Am J Neuroradiol 1998;19(8):1489-1493.
17. Kangarlu A, Bourekas EC, Ray-Chaudhury A, et al. Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla. AJNR Am J Neuroradiol 2007;28(2):262-266.
18. Wattjes MP, Lutterbey GG, Harzheim M, et al. Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T. Eur Radiol 2006;16(9):2067-2073.
19. Neema M, Guss ZD, Stankiewicz J, et al. Normal findings on brain FLAIR MRI scans at 3T. AJNR Am J Neuroradiol 2009;30:911-916.
20. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005;58(6):840-846.
21. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 1996;46(4):907-911.
22. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33(11):1444-1452.
23. Fischer JS, Rudick RA, Cutter GR. The multiple sclerosis functional composite measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS society clinical outcomes assessment task force. Mult Scler 1999;5(4):244-250.
24. Boss A, Graf H, Berger A, et al. Tissue warming and regulatory responses induced by radio frequency energy deposition on a whole-body 3-Tesla magnetic resonance imager. J Magn Reson Imaging 2007;26(5):1334-1339.
25. Benedict RH, Fischer JS, Archibald CJ, et al. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 2002;16(3):381-397.
26. Benedict RH. Effects of using same vs. alternate form memory tests in short-interval, repeated assessment in multiple sclerosis. J Int Neuropsychol Soc 2005;11(6):727-736.
27. Parmenter BA, Zivadinov R, Kerenyi L, et al. Validity of the Wisconsin card sorting and Delis-Kaplan executive function system (DKEFS) sorting tests in multiple sclerosis. J Clin Exp Neuropsychol 2007;29(2):215-223.
28. Benton AL, Sivan AB, Hamsher KS, et al. Contributions to Neuropsychological Assessment: A clinical Manual. 2nd ed. New York Oxford University Press, 1994.
29. Delis DC, Kramer JH, Kaplan E, et al. California Verbal Learning Test manual. 2nd ed. Adult version. San Antonio, TX Psychological Corp., 2000.
30. Benedict RH. Brief Visuospatial Memory Test-Revised: Professional Manual. Odessa, FL Psychological Assessment Resources Inc., 1997.
31. Gronwall DM. Paced auditory serial addition task: a measure of recovery from concussion. Percept Mot Skills 1977;44(2):367-373.
32. Smith A. Symbol Digit Modalities Test: Manual. Los Angeles Western Psychological Services, 1982.
33. Delis DC, Kaplan E, Kramer JH. Delis-Kaplan Executive Function System. San Antonio, TX Psychological Corp., 2001.
34. Radloff, LS. CES-D scale: a self report depression scale for research in the general population. Applied Psychological Measurement 1977;1:385-401.
35. Uttl B. North American adult reading test: age, norms, reliability, and validity. J Clin Exp Neuropsychol 2002;24(8):1123-1137.
36. Arnett PA, Barwick FH, Beeney JE. Depression in multiple sclerosis: review and theoretical proposal. J Int Neuropsychol Soc 2008;14(5):691-724.
37. Benedict RH, Weinstock-Guttman B, Fishman I, et al. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004;61(2):226-230.
38. Rovaris M, Filippi M, Minicucci L, et al. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR Am J Neuroradiol 2000;21(2):402-408.
39. Lazeron RH, Langdon DW, Filippi M, et al. Neuropsychological impairment in multiple sclerosis patients: the role of (juxta) cortical lesion on FLAIR. Mult Scler 2000;69(4):280-285.
40. Geurts JJ, Blezer EL, Vrenken H, et al. Does high-field MR imaging improve cortical lesion detection in multiple sclerosis? J Neurol 2008;255(2):183-191.
41. Woo JH, Henry LP, Krejza J, et al. Detection of simulated multiple sclerosis lesions on T2-weighted and FLAIR images of the brain: observer performance. Radiology 2006;241(1):206-212.
42. Pirko I, Lucchinetti CF, Sriram S, et al. Gray matter involvement in multiple sclerosis. Neurology 2007;68(9):634-642.
43. Benedict RH, Duquin JA, Jurgensen S, et al. Repeated assessment of neuropsychological deficits in multiple sclerosis using the symbol digit modalities test and the MS neuropsychological screening questionnaire. Mult Scler 2008;14(7):940-946.
44. Jacobs LD, Wende KE, Brownscheidle CM, et al. A profile of multiple sclerosis: the New York state multiple sclerosis consortium. Mult Scler 1999;5(5):369-376.
45. Stankiewicz JM, Neema M, Alsop DC, et al. Spinal cord lesions and clinical status in multiple sclerosis: a 1.5 T and 3 T MRI study. J Neurol Sci 2009;279(1-2):99-105.
46. Neema M, Goldberg-Zimring D, Guss ZD, et al. MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis. Neuroimage 2009 Mar 10; [Epub ahead of print].
47. Rovaris M, Riccitelli G, Judica E, et al. Cognitive impairment and structural brain damage in benign multiple sclerosis. Neurology 2008;71(19):1521-1256.
48. Lin X, Tench CR, Morgan PS, et al. Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008;79(4):437-441.
49. Summers M, Fisniku L, Anderson V, et al. Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier. Mult Scler 2008;14(2):197-204.
50. Cox D, Pelletier D, Genain C, et al. The unique impact of changes in normal appearing brain tissue on cognitive dysfunction in secondary progressive multiple sclerosis patients. Mult Scler 2004;10(6):626-629.
51. Rocca MA, Filippi M. Functional MRI in multiple sclerosis. J Neuroimaging 2007;17(Suppl 1):36S-41S.
52. Sicotte NL, Kern KC, Giesser BS, et al. Regional hippocampal atrophy in multiple sclerosis. Brain 2008;131(Pt 4):1134-1141.
53. Houtchens MK, Benedict RH, Killiany R, et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007;69(12):1213-1223.